Gilead Sciences, Inc.
Market Cap
$156.3B
Global Rank
#99
All-Time High
$156.3B
2026-12-31
Total Growth
+0%
since 2026
About Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) is a United States-based company in the Drug Manufacturers - General industry, part of the Healthcare sector. With a current market capitalization of $156.3B, it is ranked #99 among the world's largest companies. Its market cap peaked at $156.3B and reached as high as rank #99 in 2026.
Gilead Sciences, Inc. Market Cap History (2026–2026)
Compare Gilead Sciences, Inc.
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $156.3B | #99(↑9) | +3.8% |
| 2025 | $150.5B | #108(↑14) | +36.8% |
| 2024 | $110.0B | #122 | +18.8% |
| 2023 | $92.6B | #122(↓21) | -2.1% |
| 2022 | $94.6B | #101(↑27) | +23.9% |
| 2021 | $76.4B | #128(↑19) | +30.1% |
| 2020 | $58.7B | #147(↓39) | -6.9% |
| 2019 | $63.0B | #108(↓21) | +7.8% |
| 2018 | $58.5B | #87(↓7) | -10.1% |
| 2017 | $65.0B | #80(↓17) | +2.9% |
| 2016 | $63.2B | #63(↓27) | -27.7% |
| 2015 | $87.4B | #36(↑5) | +8.2% |
| 2014 | $80.8B | #41(↑6) | +25.5% |
| 2013 | $64.4B | #47(↑34) | +104.5% |
| 2012 | $31.5B | #81(↑39) | +79.5% |
| 2011 | $17.6B | #120(↑23) | +12.9% |
| 2010 | $15.5B | #143(↓33) | -16.2% |
| 2009 | $18.6B | #110(↓48) | -15.4% |
| 2008 | $21.9B | #62(↑50) | +11.1% |
| 2007 | $19.7B | #112(↑29) | +41.7% |
| 2006 | $13.9B | #141(↓3) | +23.5% |
| 2005 | $11.3B | #138(↑21) | +50.2% |
| 2004 | $7.5B | #159(↓4) | +20.1% |
| 2003 | $6.2B | #155(↑13) | +71.4% |
| 2002 | $3.6B | #168(↑20) | +3.5% |
| 2001 | $3.5B | #188(↑5) | +58.5% |
| 2000 | $2.2B | #193(↓23) | +53.2% |
| 1999 | $1.5B | #170(↓9) | +31.8% |
| 1998 | $1.1B | #161(↓5) | +7.4% |
| 1997 | $1.0B | #156 | +53.0% |
| 1996 | $670.1M | #156(↓18) | -21.9% |
| 1995 | $857.7M | #138(↓4) | +236.8% |
| 1994 | $254.6M | #134 |
Other Healthcare Companies
FAQ
What is Gilead Sciences, Inc.'s market cap?
Gilead Sciences, Inc. (GILD) has a market capitalization of $156.3B, making it the #99 largest company in the world by market cap.
What was Gilead Sciences, Inc.'s highest market cap?
Gilead Sciences, Inc.'s all-time high market cap was $156.3B, reached in 2026-12-31. Its highest rank was #99 in 2026.
What sector is Gilead Sciences, Inc. in?
Gilead Sciences, Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Gilead Sciences, Inc.'s market cap changed over time?
Gilead Sciences, Inc. has been tracked since 2026. Its market cap has grown by 0% from $156.3B in 2026 to $156.3B today.